Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy

Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows

Lilly to Pay Up to $2 Billion for Obesity Startup Versanis

Novo Weight Drugs Probed Over Reports of Suicidal Thoughts

Wegovy Maker Sues US Pharmacy to Block Knock-Off

Last Taboo for Hit Obesity Drug Is Asking When to Stop

Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep

The Race to Develop Weight-Loss Pills Has Some Drugmakers Falling Behind

Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet

Pfizer Halts Early-Stage Obesity Drug on Safety Concerns

Eli Lilly’s Experimental Weight-Loss Pill Show Rapid Results in Study

Novo Nordisk Plans $2.3 Billion Manufacturing Expansion in Denmark